RA: Infection Risk Lower With Enbrel or Orencia (CME/CE)
(MedPage Today) -- Studies are needed to balance harms and benefits of different biologics in individual patients. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 26, 2015 Category: Consumer Health News Source Type: news
Safety Holds Up for Anti-TNF in JIA (CME/CE)
(MedPage Today) -- Rates of serious events with Enbrel and Humira were within the expected range. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 7, 2015 Category: Geriatrics Source Type: news
Juvenile Arthritis Responding Well to Etanercept
(MedPage Today) -- Half of patients achieved minimal disease activity by 1 year. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - May 1, 2015 Category: Journals (General) Source Type: news
Stopping Enbrel Risky in Established RA (CME/CE)
(MedPage Today) -- Fewer patients with longstanding disease flared if they remained on even a half dose of etanercept, and time to flare was greater. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 22, 2015 Category: Primary Care Source Type: news
Enbrel Aids in JIA Subtype (CME/CE)
(MedPage Today) -- A 35% reduction in flare risk in enthesitis-related arthritis. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 21, 2015 Category: Pediatrics Source Type: news
Long-term Etanercept Safe, Effective in Refractory Lupus (CME/CE)
(MedPage Today) -- More than 80% of patients achieved clinical remission in the open-label study. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 12, 2015 Category: Rheumatology Source Type: news
Etanercept Improves Height Scores in JIA (CME/CE)
(MedPage Today) -- Greatest benefit seen in patients not receiving corticosteroids. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 9, 2015 Category: Geriatrics Source Type: news
Amgen’s quarterly profits jump 27 percent
Biotech company Amgen Inc. reported 27 percent growth in fourth-quarter profits, helped by strong sales and cost controls.
The Thousand Oaks-based company, which makes the rheumatoid arthritis drug Enbrel, said its quarterly earnings reached $1.3 billion, or $1.68 per share, compared with $1.02 billion, or $1.33 per share, a year earlier. Profits were boosted by an industry research tax credit at year's end, which added about 10 cents per share to earnings.
Excluding one-time items, Amgen(Nasdaq:… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 28, 2015 Category: Pharmaceuticals Source Type: news
RA Patients More Likely to Abandon Remicade (CME/CE)
(MedPage Today) -- Discontinuation rates higher for infliximab versus adalimumab and etanercept in rheumatoid arthritis. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - January 14, 2015 Category: Geriatrics Source Type: news
Sandoz loses bid to shield psoriasis drug
(Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
SPARSE Trial: Spondyloarthritis Responds to Etanercept
(MedPage Today) -- The biologic reduced patients' use of NSAIDS in placebo-controlled study. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - December 4, 2014 Category: Psychiatry Source Type: news
Etanercept for Toxic Epidermal NecrolysisEtanercept for Toxic Epidermal Necrolysis
Dr Graeme M. Lipper reviews a case series of 10 patients successfully treated with etanercept. Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 11, 2014 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news
RA: Patients in Remission Benefit From Etanercept TaperRA: Patients in Remission Benefit From Etanercept Taper
In patients with RA who achieve remission while taking etanercept and methotrexate, tapering the combination maintained remission better than methotrexate only or placebo. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news
RLO Announces Class Action Lawsuit By Enbrel Patient Against Immunex...
A California man filed a class action lawsuit against Immunex and Caremark CVS alleging that the pharmacy fails to properly refrigerate best-selling drug Enbrel when filling a mail order Caremark...(PRWeb October 17, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12252377.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 17, 2014 Category: Pharmaceuticals Source Type: news
RheumReports: Swollen Ears and Enbrel (CME/CE)
(MedPage Today) -- A 46-year-old man with ankylosing spondylitis started treatment with etanercept. His back pain improved -- but then his ears began to swell. Welcome to the rheumatologist's strange world. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 22, 2014 Category: Cardiology Source Type: news
